US Stock MarketDetailed Quotes

AVBP ArriVent BioPharma

Watchlist
  • 21.730
  • -0.140-0.64%
Close Mar 10 16:00 ET
  • 21.730
  • 0.0000.00%
Post 16:00 ET
739.17MMarket Cap-9.10P/E (TTM)

ArriVent BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
45.53%218.86M
45.53%218.86M
-9.60%150.39M
63.36%298.67M
--317.39M
-7.95%150.39M
--150.39M
--166.36M
--182.83M
338.23%163.37M
-Cash and cash equivalents
-50.60%74.29M
-50.60%74.29M
6.39%150.39M
89.23%298.67M
--317.39M
-7.95%150.39M
--150.39M
--141.36M
--157.83M
338.23%163.37M
-Short-term investments
--144.57M
--144.57M
----
----
----
--0
--0
--25M
--25M
----
Receivables
-34.30%500K
-34.30%500K
-30.12%761K
190.70%750K
--875K
52.20%761K
--761K
--1.09M
--258K
100.00%500K
-Taxes receivable
-34.30%500K
-34.30%500K
20.22%761K
190.70%750K
--875K
52.20%761K
--761K
--633K
--258K
100.00%500K
-Other receivables
----
----
----
----
----
----
----
--456K
----
----
Prepaid assets
-13.63%7.62M
-13.63%7.62M
-29.63%8.82M
-41.70%9.09M
--9.21M
-52.97%8.82M
--8.82M
--12.53M
--15.59M
245.81%18.75M
Total current assets
41.89%226.98M
41.89%226.98M
-11.12%159.97M
55.28%308.51M
--327.48M
-12.40%159.97M
--159.97M
--179.98M
--198.69M
325.18%182.62M
Non current assets
Net PPE
-47.08%154K
-47.08%154K
561.36%291K
188.16%219K
--250K
109.35%291K
--291K
--44K
--76K
--139K
-Gross PPE
-47.08%154K
-47.08%154K
561.36%291K
188.16%219K
--250K
109.35%291K
--291K
--44K
--76K
--139K
Investments and advances
--47.68M
--47.68M
----
----
----
--0
--0
----
----
----
Non current deferred assets
--0
--0
44.40%2.73M
--0
--0
--2.73M
--2.73M
--1.89M
----
--0
Other non current assets
17.76%126K
17.76%126K
50.70%107K
52.44%125K
--108K
48.61%107K
--107K
--71K
--82K
-17.24%72K
Total non current assets
1,432.36%47.96M
1,432.36%47.96M
55.95%3.13M
117.72%344K
--358K
1,383.41%3.13M
--3.13M
--2.01M
--158K
142.53%211K
Total assets
68.57%274.94M
68.57%274.94M
-10.38%163.1M
55.33%308.86M
--327.84M
-10.79%163.1M
--163.1M
--181.99M
--198.84M
324.81%182.83M
Liabilities
Current liabilities
Payables
-16.55%3.78M
-16.55%3.78M
-5.94%4.53M
-40.97%3.81M
--4.1M
46.48%4.53M
--4.53M
--4.82M
--6.46M
955.97%3.09M
-accounts payable
-16.55%3.78M
-16.55%3.78M
-5.94%4.53M
-40.97%3.81M
--4.1M
46.48%4.53M
--4.53M
--4.82M
--6.46M
955.97%3.09M
Current accrued expenses
154.71%9.17M
154.71%9.17M
31.11%3.6M
31.98%6.1M
--4.7M
46.24%3.6M
--3.6M
--2.75M
--4.62M
302.12%2.46M
Current debt and capital lease obligation
15.71%162K
15.71%162K
218.18%140K
100.00%152K
--147K
9.38%140K
--140K
--44K
--76K
--128K
-Current capital lease obligation
15.71%162K
15.71%162K
218.18%140K
100.00%152K
--147K
9.38%140K
--140K
--44K
--76K
--128K
Current liabilities
48.61%17.27M
48.61%17.27M
15.09%11.62M
-5.58%12.1M
--9.98M
39.04%11.62M
--11.62M
--10.1M
--12.81M
359.85%8.36M
Non current liabilities
Long term debt and capital lease obligation
-92.09%14K
-92.09%14K
--177K
--98K
--138K
1,509.09%177K
--177K
--0
--0
--11K
-Long term capital lease obligation
-92.09%14K
-92.09%14K
--177K
--98K
--138K
1,509.09%177K
--177K
--0
--0
--11K
Preferred securities outside stock equity
--0
--0
0.00%304.49M
--0
--0
17.31%304.49M
--304.49M
--304.49M
----
--259.57M
Total non current liabilities
-100.00%14K
-100.00%14K
0.06%304.67M
--98K
--138K
17.37%304.67M
--304.67M
--304.49M
--0
--259.58M
Total liabilities
-94.53%17.29M
-94.53%17.29M
0.54%316.29M
-4.82%12.2M
--10.12M
18.04%316.29M
--316.29M
--314.59M
--12.81M
14,638.28%267.94M
Shareholders'equity
Share capital
--3K
--3K
--0
-100.00%3K
--3K
--0
--0
--0
--304.49M
--0
-common stock
--3K
--3K
--0
-25.00%3K
--3K
--0
--0
--0
--4K
--0
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
----
--304.49M
----
Retained earnings
-50.99%-238.33M
-50.99%-238.33M
-15.51%-157.85M
-61.26%-197.14M
---175.26M
-78.33%-157.85M
---157.85M
---136.65M
---122.25M
-71.51%-88.51M
Paid-in capital
10,566.27%496.2M
10,566.27%496.2M
11.99%4.65M
12,935.69%493.79M
--492.98M
36.70%4.65M
--4.65M
--4.15M
--3.79M
14.81%3.4M
Gains losses not affecting retained earnings
---211K
---211K
----
----
----
--0
--0
----
----
----
Other equity interest
----
----
----
----
----
----
----
---106K
----
----
Total stockholders'equity
268.19%257.65M
268.19%257.65M
-15.53%-153.19M
59.47%296.66M
--317.72M
-80.00%-153.19M
---153.19M
---132.6M
--186.03M
-306.47%-85.11M
Total equity
268.19%257.65M
268.19%257.65M
-15.53%-153.19M
59.47%296.66M
--317.72M
-80.00%-153.19M
---153.19M
---132.6M
--186.03M
-306.47%-85.11M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion with Explanatory Notes
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 45.53%218.86M45.53%218.86M-9.60%150.39M63.36%298.67M--317.39M-7.95%150.39M--150.39M--166.36M--182.83M338.23%163.37M
-Cash and cash equivalents -50.60%74.29M-50.60%74.29M6.39%150.39M89.23%298.67M--317.39M-7.95%150.39M--150.39M--141.36M--157.83M338.23%163.37M
-Short-term investments --144.57M--144.57M--------------0--0--25M--25M----
Receivables -34.30%500K-34.30%500K-30.12%761K190.70%750K--875K52.20%761K--761K--1.09M--258K100.00%500K
-Taxes receivable -34.30%500K-34.30%500K20.22%761K190.70%750K--875K52.20%761K--761K--633K--258K100.00%500K
-Other receivables ------------------------------456K--------
Prepaid assets -13.63%7.62M-13.63%7.62M-29.63%8.82M-41.70%9.09M--9.21M-52.97%8.82M--8.82M--12.53M--15.59M245.81%18.75M
Total current assets 41.89%226.98M41.89%226.98M-11.12%159.97M55.28%308.51M--327.48M-12.40%159.97M--159.97M--179.98M--198.69M325.18%182.62M
Non current assets
Net PPE -47.08%154K-47.08%154K561.36%291K188.16%219K--250K109.35%291K--291K--44K--76K--139K
-Gross PPE -47.08%154K-47.08%154K561.36%291K188.16%219K--250K109.35%291K--291K--44K--76K--139K
Investments and advances --47.68M--47.68M--------------0--0------------
Non current deferred assets --0--044.40%2.73M--0--0--2.73M--2.73M--1.89M------0
Other non current assets 17.76%126K17.76%126K50.70%107K52.44%125K--108K48.61%107K--107K--71K--82K-17.24%72K
Total non current assets 1,432.36%47.96M1,432.36%47.96M55.95%3.13M117.72%344K--358K1,383.41%3.13M--3.13M--2.01M--158K142.53%211K
Total assets 68.57%274.94M68.57%274.94M-10.38%163.1M55.33%308.86M--327.84M-10.79%163.1M--163.1M--181.99M--198.84M324.81%182.83M
Liabilities
Current liabilities
Payables -16.55%3.78M-16.55%3.78M-5.94%4.53M-40.97%3.81M--4.1M46.48%4.53M--4.53M--4.82M--6.46M955.97%3.09M
-accounts payable -16.55%3.78M-16.55%3.78M-5.94%4.53M-40.97%3.81M--4.1M46.48%4.53M--4.53M--4.82M--6.46M955.97%3.09M
Current accrued expenses 154.71%9.17M154.71%9.17M31.11%3.6M31.98%6.1M--4.7M46.24%3.6M--3.6M--2.75M--4.62M302.12%2.46M
Current debt and capital lease obligation 15.71%162K15.71%162K218.18%140K100.00%152K--147K9.38%140K--140K--44K--76K--128K
-Current capital lease obligation 15.71%162K15.71%162K218.18%140K100.00%152K--147K9.38%140K--140K--44K--76K--128K
Current liabilities 48.61%17.27M48.61%17.27M15.09%11.62M-5.58%12.1M--9.98M39.04%11.62M--11.62M--10.1M--12.81M359.85%8.36M
Non current liabilities
Long term debt and capital lease obligation -92.09%14K-92.09%14K--177K--98K--138K1,509.09%177K--177K--0--0--11K
-Long term capital lease obligation -92.09%14K-92.09%14K--177K--98K--138K1,509.09%177K--177K--0--0--11K
Preferred securities outside stock equity --0--00.00%304.49M--0--017.31%304.49M--304.49M--304.49M------259.57M
Total non current liabilities -100.00%14K-100.00%14K0.06%304.67M--98K--138K17.37%304.67M--304.67M--304.49M--0--259.58M
Total liabilities -94.53%17.29M-94.53%17.29M0.54%316.29M-4.82%12.2M--10.12M18.04%316.29M--316.29M--314.59M--12.81M14,638.28%267.94M
Shareholders'equity
Share capital --3K--3K--0-100.00%3K--3K--0--0--0--304.49M--0
-common stock --3K--3K--0-25.00%3K--3K--0--0--0--4K--0
-Preferred stock --0--0--0--0--0--0--0------304.49M----
Retained earnings -50.99%-238.33M-50.99%-238.33M-15.51%-157.85M-61.26%-197.14M---175.26M-78.33%-157.85M---157.85M---136.65M---122.25M-71.51%-88.51M
Paid-in capital 10,566.27%496.2M10,566.27%496.2M11.99%4.65M12,935.69%493.79M--492.98M36.70%4.65M--4.65M--4.15M--3.79M14.81%3.4M
Gains losses not affecting retained earnings ---211K---211K--------------0--0------------
Other equity interest -------------------------------106K--------
Total stockholders'equity 268.19%257.65M268.19%257.65M-15.53%-153.19M59.47%296.66M--317.72M-80.00%-153.19M---153.19M---132.6M--186.03M-306.47%-85.11M
Total equity 268.19%257.65M268.19%257.65M-15.53%-153.19M59.47%296.66M--317.72M-80.00%-153.19M---153.19M---132.6M--186.03M-306.47%-85.11M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion------Unqualified Opinion with Explanatory Notes
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Lantheus
LNTH
+3.45%
Collegium Pharmaceutical
COLL
+2.59%
Constellation Brands
STZ
+1.73%
Halozyme Therapeutics
HALO
+0.75%
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
0.00%

Unlock the Full List